The new Medical Device Regulation (MDR) bears the potential to hamper Europe’s innovation competitiveness since reiterated, widened testing efforts are required. Especially SMEs must plan with early exits in the face of costly cli...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
CORE-MD
Coordinating Research and Evidence for Medical Devices
2M€
Cerrado
HEU-EFS
HARMONISED APPROACH TO EARLY FEASIBILITY STUDIES FOR MEDICAL...
19M€
Cerrado
INSAFEDARE
INNOVATIVE APPLICATIONS OF ASSESSMENT AND ASSURANCE OF DATA...
3M€
Cerrado
ECRIN-PPI
European clinical research infrastructures network for clini...
8M€
Cerrado
SIMCOR
In Silico testing and validation of Cardiovascular Implantab...
7M€
Cerrado
TBMED
A testing bed for the development of high risk medical devic...
10M€
Cerrado
Información proyecto MDOT
Duración del proyecto: 66 meses
Fecha Inicio: 2018-12-19
Fecha Fin: 2024-06-30
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
The new Medical Device Regulation (MDR) bears the potential to hamper Europe’s innovation competitiveness since reiterated, widened testing efforts are required. Especially SMEs must plan with early exits in the face of costly clinical studies. A structural remedial action reinstates the balance between economy and safety. The MDOT working group develops a set of coordinated measures: 1) Support with mandatory conformity assessment using a database approach based on device risk class. 2) Data exchange forum: A mutual, cross-enterprise exchange of medical device testing data on a safe and transparent platform, which aims at saving costs and streamlining clinical tests as far as possible. 2) Test foundry: Joint evaluations of commonly used parts and devices. 3) Development of advanced testing methods with a focus on in vitro and in silico data. This is all performed with regulatory support taking test beds and device innovations towards the level of clinical trials (TRL 4 – 7). This platform realizes one-stop-shop processing reducing complexity and individual costs. The operability of MDOT will be demonstrated within medical product segments growing fastest and with urgent medical need. The initial consortium consists of MD industry R&D, translational institutions and networks as well as clinical research centers. It will grant open access to new clients already during the funding period. Goal of the project is to implement the platform as a meta-network to preserve MedTech innovation and economic strength, reduce animal testing, and support MDR’s new level of patient safety.